NASDAQ:ETON

Eton Pharmaceuticals Earning Date

USA |NASDAQ |USD

ETON Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.13 $-0.08 $-0.31
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $3.04M $3.07M $-161.00K

Eton Pharmaceuticals's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

ETON Earnings Date & History Chart

ETON Earnings & Revenue Forecast

ETON Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $0.19 $0.05 $0.33
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $0.18 $0.02 $0.34
Dec 2022 2 $0.27 $0.14 $0.40

ETON Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.33 $0.19 $0.09
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.34 $0.23 $0.23
Dec 2022 0 / 0 $0.40 $0.29 $0.29

ETON Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $12.64M $7.80M $17.47M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $30.64M $24.09M $37.20M
Dec 2022 2 $55.19M $52.14M $58.24M

ETON Earnings Date & Revenue History

ETON Earnings History

|
Show More
Show More

ETON Revenue History

|
Show More
Show More

Eton Pharmaceuticals Next Earnings Date & Report

ETON Next Earnings Date & Report Preview: Sep 2021 (FQ)

ETON's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 2 analysts, the average EPS estimation for Eton Pharmaceuticals's next quarterly earnings is $-0.13, with a low EPS estimation of $-0.16, and a high estimation of $-0.11.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.11, the last 2 month trend is $-0.02, and the 3 month trend is $0.07.

Based on 1 analysts, the average revenue estimation is $3.04M, with a low revenue estimation of $1.32M, and a high estimation of $4.76M.

Eton Pharmaceuticals Previous Earnings Dates & Reports

ETON Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Eton Pharmaceuticals's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.

ETON's earnings per share (EPS) was $-0.08, beating the consensus analysts forecast of $-0.14 by 42.86%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by -142.11%, and higher than the same period a year before (Jun 2020) by -65.22%.

Revenues were $3.07M, worse than the forecast of $3.81M by -19.50%, down by -74.22% from the previous quarter , and up by 15235.00% from the same period last year.

The company reported a net income of $-2.02M.

Free cash flow for the quarter was $-372.00K , compared to $3.71M last quarter and $-2.85M a year before.

ETON ended the quarter with $6.81M in total debt, a decrease of -4.82% compared to the previous quarter, and an increase of 37.69% compared to the same quarter a year before.

ETON Previous Earnings Date & Report Recap: Dec 2020 (FY)

Eton Pharmaceuticals's previous annual earnings date was Mar 16, 2021 for its fiscal year ended Dec 31, 2020.

ETON's earnings per share (EPS) was $-1.33, missing the consensus analysts forecast of $-1.26 by 5.56% , and lower than the previous year's EPS (Dec 2019) by 28.70%.

Revenues were $39.00K, worse than the forecast of $1.61M by -97.58%, and down by -95.93% from previous year's revenue.

The company reported a net income of $-27.97M.

Eton Pharmaceuticals reported a free cash flow of $-22.40M for its fiscal year, compared to $-19.87M a year ago.

The company ended the fiscal year with $7.04M in total debt, an increase of 54.49% compared to the previous year.